article thumbnail

Which pharma companies have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the… The post Which pharma companies have the most supplementary protection certificates?

article thumbnail

Which pharma companies have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drug companies with the most supplementary protection certificates (SPCs). The post Which pharma companies have the most supplementary protection certificates? SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the….

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which pharma companies have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drug companies with the most supplementary protection certificates (SPCs). The post Which pharma companies have the most supplementary protection certificates? SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the….

article thumbnail

Which pharma companies have the most supplementary protection certificates?

Drug Patent Watch

This chart shows the drug companies with the most supplementary protection certificates (SPCs). The post Which pharma companies have the most supplementary protection certificates? SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the….

article thumbnail

The top biopharma conferences in 2025

BioPharma Drive: Drug Pricing

Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies' research progress. Here’s a list of conferences to watch in 2025.

article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1.

article thumbnail

Using de-identified lab data to find patients, target physicians and expedite treatment

BioPharma Drive: Drug Pricing

Many pharma companies are now using de-identified lab data to identify potential patients and their physicians in time to impact the patient’s treatment plan. In this Q&A, learn how lab data can be used to increase patient access.